Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.

Revenue
+3.95%
EPS
+34.8%
Free cash flow
−7.09%
Total debt
+15.6%

Quarter to September 2026, against a year earlier

86.21 0.90 +1.05%
Market cap
$9.4B
P/E
23.0×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

Henry Schein, Inc. (HSIC) P/B ratio

Alert me on P/B ratio

As of 6 November 2026, Henry Schein, Inc. (HSIC) trades at a P/B ratio of 2.5×. Over the past ten years it has ranged from 1.8× (March 2020) to 4.1× (June 2017); the current reading is higher than 38% of that period. That is above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 2.3× 7.59%
FY2024 2.2× (5.41%)
FY2023 2.3× (13.00%)
FY2022 2.6× (1.06%)
FY2021 2.7× 11.79%
FY2020 2.4× (11.98%)
FY2019 2.7× 3.49%
FY2018 2.6× (14.70%)
FY2017 3.1× (11.83%)
FY2016 3.5× (1.97%)

Quarterly newest first

Period P/B ratio Change
Sep 2026 2.4× (1.39%)
Jun 2026 2.5× 14.85%
Mar 2026 2.2× (7.70%)
Dec 2025 2.3× 18.10%
43 more quarters

Against its own ten years

Low 1.8× High 4.1×
Ten-year median 2.7×
Current reading's percentile 41

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on HSIC